2.96
price down icon7.21%   -0.23
after-market Dopo l'orario di chiusura: 2.95 -0.010 -0.34%
loading

Cassava Sciences Inc Azioni (SAVA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
84.63%
45.39
24.59 30.62 61.40 19.93
Operating Income/Loss
84.63%
-45.39
-24.59 -30.62 -61.40 -19.93
Income/Loss From Continuing Operations Before Tax
88.97%
-44.22
-23.40 -27.94 6.155 25.04
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
88.97%
-44.22
-23.40 -27.94 6.155 25.04
Net Income/Loss
88.97%
-44.22
-23.40 -27.94 6.155 25.04
Preferred Stock Dividends And Other Adjustments
-
- - - 43.79
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.10%
48.31
48.26 47.98 46.20 43.00
Diluted Average Shares
0.10%
48.31
48.26 47.98 46.20 44.10
Basic Earnings Per Share
91.67%
-0.92
-0.48 -0.58 0.13 0.58
Diluted Earnings Per Share
91.67%
-0.92
-0.48 -0.58 0.13 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
Capitalizzazione:     |  Volume (24 ore):